Thirty-day mortality outcomes with checkpoint inhibitors for stage IV NSCLC - Amsterdam 2025

Contemporary approach for lung cancer care in the real world and future biomarkers

Chair(s): Fatma Chermiti Ben Abdallah, Iwona Kwiecien

Session type: Poster session

Thirty-day mortality outcomes with checkpoint inhibitors for stage IV NSCLC

Anke Santema

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Pulmonary adenocarcinoma:a silent epidemic in non-Smokers with no medical history

Sirine Arfa

Poster

Abstract

Efficacy of ezetimibe-statin combination therapy in respiratory cancer risk

Taehwa Kim

Abstract

Does COPD affect the course of lung cancer in women?

Anna Trojnar

Poster

Abstract

Utility of diagnostic and staging tools in lung cancer patients with advanced-disease and poor performance status

Hafiz Gulzeb Kamil

Poster

Abstract

Neoadjuvant chemoimmunotherapy impairs diffusing capacity of the lung and increases airway resistance

Özlem Okumus

Poster

Abstract

Whats about the lung cancer of the women without tobacco smoking in eastern of Algeria?

Ardjouna Manaa

Poster

Abstract

Chemotherapy strategies and outcomes in stage IV lung adenocarcinoma in non-smokers

Sirine Arfa

Poster

Abstract

The role of Tumour staging in prognostic implications for cancer recurrence a retrospective study

Pooja Radia

Poster

Abstract

One-year survival results of metastatic non-small cell lung cancer patients receiving cryotherapy and immunotherapy

Gediminas Vasiliauskas

Poster

Abstract

DLCO as a screening tool for oncogene addiction in NSCLC: a retrospective study

Guido Levi

Poster

Abstract

Non-small cell lung cancer metastases to adrenal glands are not differentially sensitive to immune checkpoint inhibitors than other organs

Charles Soutif

Abstract

Delays in the diagnostic pathway for lung cancer

Anna Davies

Poster

Abstract

Serial change of KL-6 and development of PD-1/PD-L1 inhibitor-related pneumonitis in non-small cell lung cancer

Sung Yong Lee

Poster

Abstract

Comparison of turnaround time and mutation concordance between liquid and tissue biopsy in advanced lung cancer

Julyan Al-fori

Poster

Abstract

Clinical characteristics and molecular profile of patients diagnosed with Non Small Cell Lung Cancer in a Tertiary Hospital: A Cross Sectional Retrospective Study

Mary Bloom Beup

Poster

Abstract

Challenges and strategies in the management of localized lung adenocarcinoma in non-smokers

Sirine Arfa

Poster

Abstract

Thirty-day mortality outcomes with checkpoint inhibitors for stage IV NSCLC

Anke Santema

Poster

Abstract

Utility of NGS for molecular profiling of tumors from cell-free DNA (cfDNA) in the diagnosis of non-small cell lung cancer (NSCLC)

Mateja Marc Malovrh

Poster

Abstract

The lung cancer patient pathway in Greece; unravelling the Minotaurs labyrinth

Georgia Hardavella

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}